ArticleJournal of atherosclerosis and thrombosis2021

Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease.

Hayato TadaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.